nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetylcysteine—SLC22A6—Stavudine—acquired immunodeficiency syndrome	0.128	0.192	CbGbCtD
Acetylcysteine—SLC22A6—Didanosine—acquired immunodeficiency syndrome	0.097	0.146	CbGbCtD
Acetylcysteine—SLCO1B1—Indinavir—acquired immunodeficiency syndrome	0.0942	0.141	CbGbCtD
Acetylcysteine—SLCO1B1—Nelfinavir—acquired immunodeficiency syndrome	0.0914	0.137	CbGbCtD
Acetylcysteine—SLCO1B1—Saquinavir—acquired immunodeficiency syndrome	0.0827	0.124	CbGbCtD
Acetylcysteine—SLCO1B1—Ritonavir—acquired immunodeficiency syndrome	0.0827	0.124	CbGbCtD
Acetylcysteine—SLC22A6—Zidovudine—acquired immunodeficiency syndrome	0.051	0.0765	CbGbCtD
Acetylcysteine—SLC22A6—Lamivudine—acquired immunodeficiency syndrome	0.0394	0.0592	CbGbCtD
Acetylcysteine—GRIN2B—nerve—acquired immunodeficiency syndrome	0.00588	0.0552	CbGeAlD
Acetylcysteine—GRIN2A—nerve—acquired immunodeficiency syndrome	0.00514	0.0483	CbGeAlD
Acetylcysteine—ACY1—skin of body—acquired immunodeficiency syndrome	0.00355	0.0333	CbGeAlD
Acetylcysteine—GSS—blood plasma—acquired immunodeficiency syndrome	0.0034	0.0319	CbGeAlD
Acetylcysteine—ACY1—digestive system—acquired immunodeficiency syndrome	0.00284	0.0267	CbGeAlD
Acetylcysteine—SLCO1B1—blood plasma—acquired immunodeficiency syndrome	0.0025	0.0235	CbGeAlD
Acetylcysteine—CHUK—skin of body—acquired immunodeficiency syndrome	0.00245	0.023	CbGeAlD
Acetylcysteine—ACY1—lung—acquired immunodeficiency syndrome	0.00237	0.0223	CbGeAlD
Acetylcysteine—ACY1—nervous system—acquired immunodeficiency syndrome	0.0022	0.0206	CbGeAlD
Acetylcysteine—ACY1—central nervous system—acquired immunodeficiency syndrome	0.00212	0.0198	CbGeAlD
Acetylcysteine—CHUK—lymphoid tissue—acquired immunodeficiency syndrome	0.00199	0.0186	CbGeAlD
Acetylcysteine—CHUK—digestive system—acquired immunodeficiency syndrome	0.00196	0.0184	CbGeAlD
Acetylcysteine—CHUK—blood—acquired immunodeficiency syndrome	0.00187	0.0175	CbGeAlD
Acetylcysteine—GSS—retina—acquired immunodeficiency syndrome	0.00186	0.0175	CbGeAlD
Acetylcysteine—GRIN2D—spinal cord—acquired immunodeficiency syndrome	0.00185	0.0173	CbGeAlD
Acetylcysteine—ACY1—brain—acquired immunodeficiency syndrome	0.00168	0.0158	CbGeAlD
Acetylcysteine—IKBKB—skin of body—acquired immunodeficiency syndrome	0.00167	0.0156	CbGeAlD
Acetylcysteine—GRIN1—spinal cord—acquired immunodeficiency syndrome	0.00165	0.0154	CbGeAlD
Acetylcysteine—CHUK—lung—acquired immunodeficiency syndrome	0.00164	0.0154	CbGeAlD
Acetylcysteine—GSS—skin of body—acquired immunodeficiency syndrome	0.00164	0.0153	CbGeAlD
Acetylcysteine—SLC7A11—digestive system—acquired immunodeficiency syndrome	0.00161	0.0152	CbGeAlD
Acetylcysteine—GRIN2B—spinal cord—acquired immunodeficiency syndrome	0.00157	0.0147	CbGeAlD
Acetylcysteine—GRIN2D—nervous system—acquired immunodeficiency syndrome	0.00156	0.0146	CbGeAlD
Acetylcysteine—GRIN2D—central nervous system—acquired immunodeficiency syndrome	0.0015	0.0141	CbGeAlD
Acetylcysteine—SLC7A11—spinal cord—acquired immunodeficiency syndrome	0.00148	0.0139	CbGeAlD
Acetylcysteine—GRIN3A—nervous system—acquired immunodeficiency syndrome	0.00146	0.0137	CbGeAlD
Acetylcysteine—GRIN3A—central nervous system—acquired immunodeficiency syndrome	0.00141	0.0132	CbGeAlD
Acetylcysteine—GRIN1—nervous system—acquired immunodeficiency syndrome	0.00139	0.013	CbGeAlD
Acetylcysteine—GRIN2A—spinal cord—acquired immunodeficiency syndrome	0.00137	0.0129	CbGeAlD
Acetylcysteine—IKBKB—lymphoid tissue—acquired immunodeficiency syndrome	0.00135	0.0127	CbGeAlD
Acetylcysteine—SLC7A11—lung—acquired immunodeficiency syndrome	0.00135	0.0127	CbGeAlD
Acetylcysteine—GRIN1—central nervous system—acquired immunodeficiency syndrome	0.00134	0.0125	CbGeAlD
Acetylcysteine—IKBKB—digestive system—acquired immunodeficiency syndrome	0.00133	0.0125	CbGeAlD
Acetylcysteine—GRIN2B—nervous system—acquired immunodeficiency syndrome	0.00132	0.0124	CbGeAlD
Acetylcysteine—GRIN2A—vagina—acquired immunodeficiency syndrome	0.00132	0.0124	CbGeAlD
Acetylcysteine—GSS—digestive system—acquired immunodeficiency syndrome	0.00131	0.0123	CbGeAlD
Acetylcysteine—GRIN2B—central nervous system—acquired immunodeficiency syndrome	0.00127	0.012	CbGeAlD
Acetylcysteine—IKBKB—blood—acquired immunodeficiency syndrome	0.00127	0.0119	CbGeAlD
Acetylcysteine—SLC7A11—nervous system—acquired immunodeficiency syndrome	0.00125	0.0117	CbGeAlD
Acetylcysteine—GSS—blood—acquired immunodeficiency syndrome	0.00125	0.0117	CbGeAlD
Acetylcysteine—GSS—bone marrow—acquired immunodeficiency syndrome	0.00121	0.0113	CbGeAlD
Acetylcysteine—SLC7A11—central nervous system—acquired immunodeficiency syndrome	0.0012	0.0113	CbGeAlD
Acetylcysteine—GSS—spinal cord—acquired immunodeficiency syndrome	0.0012	0.0113	CbGeAlD
Acetylcysteine—GRIN2D—brain—acquired immunodeficiency syndrome	0.00119	0.0112	CbGeAlD
Acetylcysteine—IKBKB—vagina—acquired immunodeficiency syndrome	0.00118	0.011	CbGeAlD
Acetylcysteine—CHUK—brain—acquired immunodeficiency syndrome	0.00116	0.0109	CbGeAlD
Acetylcysteine—GRIN2A—nervous system—acquired immunodeficiency syndrome	0.00116	0.0109	CbGeAlD
Acetylcysteine—GSS—vagina—acquired immunodeficiency syndrome	0.00116	0.0108	CbGeAlD
Acetylcysteine—CHUK—lymph node—acquired immunodeficiency syndrome	0.00112	0.0105	CbGeAlD
Acetylcysteine—GRIN3A—brain—acquired immunodeficiency syndrome	0.00112	0.0105	CbGeAlD
Acetylcysteine—GRIN2A—central nervous system—acquired immunodeficiency syndrome	0.00111	0.0104	CbGeAlD
Acetylcysteine—IKBKB—lung—acquired immunodeficiency syndrome	0.00111	0.0104	CbGeAlD
Acetylcysteine—GSS—lung—acquired immunodeficiency syndrome	0.00109	0.0103	CbGeAlD
Acetylcysteine—GRIN1—brain—acquired immunodeficiency syndrome	0.00106	0.00995	CbGeAlD
Acetylcysteine—IKBKB—nervous system—acquired immunodeficiency syndrome	0.00103	0.00967	CbGeAlD
Acetylcysteine—GSS—nervous system—acquired immunodeficiency syndrome	0.00101	0.00949	CbGeAlD
Acetylcysteine—GRIN2B—brain—acquired immunodeficiency syndrome	0.00101	0.00949	CbGeAlD
Acetylcysteine—IKBKB—central nervous system—acquired immunodeficiency syndrome	0.000992	0.00931	CbGeAlD
Acetylcysteine—GSS—central nervous system—acquired immunodeficiency syndrome	0.000974	0.00914	CbGeAlD
Acetylcysteine—SLCO1B1—digestive system—acquired immunodeficiency syndrome	0.000962	0.00902	CbGeAlD
Acetylcysteine—SLC7A11—brain—acquired immunodeficiency syndrome	0.000955	0.00896	CbGeAlD
Acetylcysteine—SLCO1B1—blood—acquired immunodeficiency syndrome	0.000916	0.0086	CbGeAlD
Acetylcysteine—GRIN2A—brain—acquired immunodeficiency syndrome	0.000884	0.0083	CbGeAlD
Acetylcysteine—IKBKB—brain—acquired immunodeficiency syndrome	0.000788	0.00739	CbGeAlD
Acetylcysteine—GSS—brain—acquired immunodeficiency syndrome	0.000773	0.00726	CbGeAlD
Acetylcysteine—IKBKB—lymph node—acquired immunodeficiency syndrome	0.000761	0.00714	CbGeAlD
Acetylcysteine—GSS—lymph node—acquired immunodeficiency syndrome	0.000747	0.00701	CbGeAlD
Acetylcysteine—SLC22A6—brain—acquired immunodeficiency syndrome	0.000738	0.00692	CbGeAlD
Acetylcysteine—Cardiac disorder—Efavirenz—acquired immunodeficiency syndrome	0.000563	0.0029	CcSEcCtD
Acetylcysteine—Stomatitis—Saquinavir—acquired immunodeficiency syndrome	0.000561	0.00289	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Abacavir—acquired immunodeficiency syndrome	0.000556	0.00286	CcSEcCtD
Acetylcysteine—Oedema—Abacavir—acquired immunodeficiency syndrome	0.000556	0.00286	CcSEcCtD
Acetylcysteine—Angiopathy—Efavirenz—acquired immunodeficiency syndrome	0.00055	0.00284	CcSEcCtD
Acetylcysteine—Skin disorder—Nelfinavir—acquired immunodeficiency syndrome	0.00055	0.00283	CcSEcCtD
Acetylcysteine—Angioedema—Zidovudine—acquired immunodeficiency syndrome	0.000549	0.00283	CcSEcCtD
Acetylcysteine—Skin disorder—Stavudine—acquired immunodeficiency syndrome	0.000548	0.00282	CcSEcCtD
Acetylcysteine—Immune system disorder—Efavirenz—acquired immunodeficiency syndrome	0.000548	0.00282	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Nelfinavir—acquired immunodeficiency syndrome	0.000547	0.00282	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000547	0.00282	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Stavudine—acquired immunodeficiency syndrome	0.000546	0.00281	CcSEcCtD
Acetylcysteine—Skin disorder—Abacavir—acquired immunodeficiency syndrome	0.00054	0.00278	CcSEcCtD
Acetylcysteine—Syncope—Zidovudine—acquired immunodeficiency syndrome	0.000539	0.00278	CcSEcCtD
Acetylcysteine—Stomatitis—Lamivudine—acquired immunodeficiency syndrome	0.000535	0.00276	CcSEcCtD
Acetylcysteine—Pharyngitis—Ritonavir—acquired immunodeficiency syndrome	0.000533	0.00274	CcSEcCtD
Acetylcysteine—Loss of consciousness—Zidovudine—acquired immunodeficiency syndrome	0.000528	0.00272	CcSEcCtD
Acetylcysteine—Erythema—Efavirenz—acquired immunodeficiency syndrome	0.000528	0.00272	CcSEcCtD
Acetylcysteine—Sweating—Lamivudine—acquired immunodeficiency syndrome	0.000526	0.00271	CcSEcCtD
Acetylcysteine—Cough—Zidovudine—acquired immunodeficiency syndrome	0.000525	0.0027	CcSEcCtD
Acetylcysteine—Somnolence—Nevirapine—acquired immunodeficiency syndrome	0.00052	0.00268	CcSEcCtD
Acetylcysteine—Hypotension—Abacavir—acquired immunodeficiency syndrome	0.00052	0.00268	CcSEcCtD
Acetylcysteine—Body temperature increased—Didanosine—acquired immunodeficiency syndrome	0.000514	0.00265	CcSEcCtD
Acetylcysteine—Pharyngitis—Saquinavir—acquired immunodeficiency syndrome	0.000513	0.00264	CcSEcCtD
Acetylcysteine—Angioedema—Indinavir—acquired immunodeficiency syndrome	0.000511	0.00263	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Zidovudine—acquired immunodeficiency syndrome	0.000508	0.00262	CcSEcCtD
Acetylcysteine—Erythema—Delavirdine—acquired immunodeficiency syndrome	0.000505	0.0026	CcSEcCtD
Acetylcysteine—Dyspnoea—Nelfinavir—acquired immunodeficiency syndrome	0.000505	0.0026	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Nevirapine—acquired immunodeficiency syndrome	0.000505	0.0026	CcSEcCtD
Acetylcysteine—Pruritus—Amprenavir—acquired immunodeficiency syndrome	0.000505	0.0026	CcSEcCtD
Acetylcysteine—Somnolence—Nelfinavir—acquired immunodeficiency syndrome	0.000503	0.00259	CcSEcCtD
Acetylcysteine—Somnolence—Stavudine—acquired immunodeficiency syndrome	0.000502	0.00258	CcSEcCtD
Acetylcysteine—Syncope—Indinavir—acquired immunodeficiency syndrome	0.000501	0.00258	CcSEcCtD
Acetylcysteine—Dyspepsia—Nelfinavir—acquired immunodeficiency syndrome	0.000498	0.00257	CcSEcCtD
Acetylcysteine—Flushing—Ritonavir—acquired immunodeficiency syndrome	0.000498	0.00257	CcSEcCtD
Acetylcysteine—Cardiac disorder—Ritonavir—acquired immunodeficiency syndrome	0.000498	0.00257	CcSEcCtD
Acetylcysteine—Dyspepsia—Stavudine—acquired immunodeficiency syndrome	0.000497	0.00256	CcSEcCtD
Acetylcysteine—Dyspnoea—Abacavir—acquired immunodeficiency syndrome	0.000496	0.00255	CcSEcCtD
Acetylcysteine—Loss of consciousness—Indinavir—acquired immunodeficiency syndrome	0.000491	0.00253	CcSEcCtD
Acetylcysteine—Oedema—Zidovudine—acquired immunodeficiency syndrome	0.000491	0.00253	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Zidovudine—acquired immunodeficiency syndrome	0.000491	0.00253	CcSEcCtD
Acetylcysteine—Pharyngitis—Lamivudine—acquired immunodeficiency syndrome	0.000489	0.00252	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Nelfinavir—acquired immunodeficiency syndrome	0.000489	0.00252	CcSEcCtD
Acetylcysteine—Cough—Indinavir—acquired immunodeficiency syndrome	0.000488	0.00251	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Stavudine—acquired immunodeficiency syndrome	0.000487	0.00251	CcSEcCtD
Acetylcysteine—Angiopathy—Ritonavir—acquired immunodeficiency syndrome	0.000487	0.00251	CcSEcCtD
Acetylcysteine—Immune system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000485	0.0025	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000484	0.00249	CcSEcCtD
Acetylcysteine—Shock—Zidovudine—acquired immunodeficiency syndrome	0.000483	0.00249	CcSEcCtD
Acetylcysteine—Angioedema—Efavirenz—acquired immunodeficiency syndrome	0.000483	0.00249	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	0.00048	0.00247	CcSEcCtD
Acetylcysteine—Cardiac disorder—Saquinavir—acquired immunodeficiency syndrome	0.00048	0.00247	CcSEcCtD
Acetylcysteine—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.000479	0.00247	CcSEcCtD
Acetylcysteine—Skin disorder—Zidovudine—acquired immunodeficiency syndrome	0.000477	0.00245	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Zidovudine—acquired immunodeficiency syndrome	0.000474	0.00244	CcSEcCtD
Acetylcysteine—Syncope—Efavirenz—acquired immunodeficiency syndrome	0.000474	0.00244	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Indinavir—acquired immunodeficiency syndrome	0.000473	0.00243	CcSEcCtD
Acetylcysteine—Angiopathy—Saquinavir—acquired immunodeficiency syndrome	0.000469	0.00241	CcSEcCtD
Acetylcysteine—Immune system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000467	0.0024	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000466	0.0024	CcSEcCtD
Acetylcysteine—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.000464	0.00239	CcSEcCtD
Acetylcysteine—Loss of consciousness—Efavirenz—acquired immunodeficiency syndrome	0.000464	0.00239	CcSEcCtD
Acetylcysteine—Body temperature increased—Nevirapine—acquired immunodeficiency syndrome	0.000462	0.00238	CcSEcCtD
Acetylcysteine—Angioedema—Delavirdine—acquired immunodeficiency syndrome	0.000462	0.00238	CcSEcCtD
Acetylcysteine—Cough—Efavirenz—acquired immunodeficiency syndrome	0.000461	0.00237	CcSEcCtD
Acetylcysteine—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.00046	0.00237	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Indinavir—acquired immunodeficiency syndrome	0.000456	0.00235	CcSEcCtD
Acetylcysteine—Oedema—Indinavir—acquired immunodeficiency syndrome	0.000456	0.00235	CcSEcCtD
Acetylcysteine—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.000453	0.00234	CcSEcCtD
Acetylcysteine—Syncope—Delavirdine—acquired immunodeficiency syndrome	0.000453	0.00233	CcSEcCtD
Acetylcysteine—Erythema—Saquinavir—acquired immunodeficiency syndrome	0.00045	0.00232	CcSEcCtD
Acetylcysteine—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.00045	0.00232	CcSEcCtD
Acetylcysteine—Rash—Amprenavir—acquired immunodeficiency syndrome	0.00045	0.00232	CcSEcCtD
Acetylcysteine—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.000449	0.00231	CcSEcCtD
Acetylcysteine—Shock—Indinavir—acquired immunodeficiency syndrome	0.000449	0.00231	CcSEcCtD
Acetylcysteine—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.000448	0.00231	CcSEcCtD
Acetylcysteine—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.000448	0.00231	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Efavirenz—acquired immunodeficiency syndrome	0.000447	0.0023	CcSEcCtD
Acetylcysteine—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.000446	0.0023	CcSEcCtD
Acetylcysteine—Immune system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000445	0.00229	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000444	0.00229	CcSEcCtD
Acetylcysteine—Loss of consciousness—Delavirdine—acquired immunodeficiency syndrome	0.000444	0.00229	CcSEcCtD
Acetylcysteine—Skin disorder—Indinavir—acquired immunodeficiency syndrome	0.000443	0.00228	CcSEcCtD
Acetylcysteine—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.000442	0.00228	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Indinavir—acquired immunodeficiency syndrome	0.000441	0.00227	CcSEcCtD
Acetylcysteine—Cough—Delavirdine—acquired immunodeficiency syndrome	0.000441	0.00227	CcSEcCtD
Acetylcysteine—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.00044	0.00226	CcSEcCtD
Acetylcysteine—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.000437	0.00225	CcSEcCtD
Acetylcysteine—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.000436	0.00225	CcSEcCtD
Acetylcysteine—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.000432	0.00222	CcSEcCtD
Acetylcysteine—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.000431	0.00222	CcSEcCtD
Acetylcysteine—Erythema—Lamivudine—acquired immunodeficiency syndrome	0.000429	0.00221	CcSEcCtD
Acetylcysteine—Shock—Efavirenz—acquired immunodeficiency syndrome	0.000424	0.00218	CcSEcCtD
Acetylcysteine—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000424	0.00218	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000424	0.00218	CcSEcCtD
Acetylcysteine—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.000421	0.00217	CcSEcCtD
Acetylcysteine—Syncope—Ritonavir—acquired immunodeficiency syndrome	0.000419	0.00216	CcSEcCtD
Acetylcysteine—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.000419	0.00216	CcSEcCtD
Acetylcysteine—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000417	0.00215	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.000417	0.00215	CcSEcCtD
Acetylcysteine—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000416	0.00214	CcSEcCtD
Acetylcysteine—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000414	0.00213	CcSEcCtD
Acetylcysteine—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000413	0.00213	CcSEcCtD
Acetylcysteine—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.000412	0.00212	CcSEcCtD
Acetylcysteine—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.000411	0.00212	CcSEcCtD
Acetylcysteine—Rash—Didanosine—acquired immunodeficiency syndrome	0.00041	0.00211	CcSEcCtD
Acetylcysteine—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.00041	0.00211	CcSEcCtD
Acetylcysteine—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.00041	0.00211	CcSEcCtD
Acetylcysteine—Cough—Ritonavir—acquired immunodeficiency syndrome	0.000408	0.0021	CcSEcCtD
Acetylcysteine—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000407	0.0021	CcSEcCtD
Acetylcysteine—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000406	0.00209	CcSEcCtD
Acetylcysteine—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000406	0.00209	CcSEcCtD
Acetylcysteine—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000403	0.00208	CcSEcCtD
Acetylcysteine—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000403	0.00207	CcSEcCtD
Acetylcysteine—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000402	0.00207	CcSEcCtD
Acetylcysteine—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000401	0.00206	CcSEcCtD
Acetylcysteine—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000401	0.00206	CcSEcCtD
Acetylcysteine—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000399	0.00206	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000399	0.00205	CcSEcCtD
Acetylcysteine—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000395	0.00204	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000395	0.00204	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000394	0.00203	CcSEcCtD
Acetylcysteine—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000393	0.00203	CcSEcCtD
Acetylcysteine—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000392	0.00202	CcSEcCtD
Acetylcysteine—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000392	0.00202	CcSEcCtD
Acetylcysteine—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.00039	0.00201	CcSEcCtD
Acetylcysteine—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000388	0.002	CcSEcCtD
Acetylcysteine—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000386	0.00199	CcSEcCtD
Acetylcysteine—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000385	0.00199	CcSEcCtD
Acetylcysteine—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000385	0.00198	CcSEcCtD
Acetylcysteine—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000384	0.00198	CcSEcCtD
Acetylcysteine—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000383	0.00197	CcSEcCtD
Acetylcysteine—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000381	0.00196	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.00038	0.00196	CcSEcCtD
Acetylcysteine—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000379	0.00195	CcSEcCtD
Acetylcysteine—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000377	0.00194	CcSEcCtD
Acetylcysteine—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000375	0.00193	CcSEcCtD
Acetylcysteine—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000374	0.00193	CcSEcCtD
Acetylcysteine—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000374	0.00193	CcSEcCtD
Acetylcysteine—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000373	0.00192	CcSEcCtD
Acetylcysteine—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000372	0.00192	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000372	0.00192	CcSEcCtD
Acetylcysteine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000372	0.00191	CcSEcCtD
Acetylcysteine—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.00037	0.00191	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000369	0.0019	CcSEcCtD
Acetylcysteine—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000369	0.0019	CcSEcCtD
Acetylcysteine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000368	0.0019	CcSEcCtD
Acetylcysteine—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000368	0.00189	CcSEcCtD
Acetylcysteine—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000368	0.00189	CcSEcCtD
Acetylcysteine—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000367	0.00189	CcSEcCtD
Acetylcysteine—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000367	0.00189	CcSEcCtD
Acetylcysteine—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000363	0.00187	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000363	0.00187	CcSEcCtD
Acetylcysteine—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000362	0.00187	CcSEcCtD
Acetylcysteine—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000361	0.00186	CcSEcCtD
Acetylcysteine—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000361	0.00186	CcSEcCtD
Acetylcysteine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.00036	0.00185	CcSEcCtD
Acetylcysteine—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000359	0.00185	CcSEcCtD
Acetylcysteine—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000357	0.00184	CcSEcCtD
Acetylcysteine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000357	0.00184	CcSEcCtD
Acetylcysteine—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000357	0.00184	CcSEcCtD
Acetylcysteine—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000356	0.00184	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000356	0.00183	CcSEcCtD
Acetylcysteine—Rash—Stavudine—acquired immunodeficiency syndrome	0.000356	0.00183	CcSEcCtD
Acetylcysteine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000356	0.00183	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000355	0.00183	CcSEcCtD
Acetylcysteine—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000354	0.00182	CcSEcCtD
Acetylcysteine—Rash—Abacavir—acquired immunodeficiency syndrome	0.000351	0.00181	CcSEcCtD
Acetylcysteine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.00035	0.0018	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.00035	0.0018	CcSEcCtD
Acetylcysteine—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.00035	0.0018	CcSEcCtD
Acetylcysteine—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000347	0.00179	CcSEcCtD
Acetylcysteine—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000347	0.00179	CcSEcCtD
Acetylcysteine—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000345	0.00177	CcSEcCtD
Acetylcysteine—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000343	0.00177	CcSEcCtD
Acetylcysteine—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000342	0.00176	CcSEcCtD
Acetylcysteine—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000341	0.00176	CcSEcCtD
Acetylcysteine—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.00034	0.00175	CcSEcCtD
Acetylcysteine—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.00034	0.00175	CcSEcCtD
Acetylcysteine—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000339	0.00175	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000339	0.00174	CcSEcCtD
Acetylcysteine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000336	0.00173	CcSEcCtD
Acetylcysteine—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000336	0.00173	CcSEcCtD
Acetylcysteine—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000336	0.00173	CcSEcCtD
Acetylcysteine—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000335	0.00173	CcSEcCtD
Acetylcysteine—Nausea—Abacavir—acquired immunodeficiency syndrome	0.00033	0.0017	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000329	0.0017	CcSEcCtD
Acetylcysteine—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000328	0.00169	CcSEcCtD
Acetylcysteine—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000327	0.00169	CcSEcCtD
Acetylcysteine—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000327	0.00169	CcSEcCtD
Acetylcysteine—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000326	0.00168	CcSEcCtD
Acetylcysteine—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000326	0.00168	CcSEcCtD
Acetylcysteine—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000324	0.00167	CcSEcCtD
Acetylcysteine—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000323	0.00166	CcSEcCtD
Acetylcysteine—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000323	0.00166	CcSEcCtD
Acetylcysteine—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000318	0.00164	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000317	0.00163	CcSEcCtD
Acetylcysteine—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000312	0.00161	CcSEcCtD
Acetylcysteine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000312	0.00161	CcSEcCtD
Acetylcysteine—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000311	0.0016	CcSEcCtD
Acetylcysteine—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000309	0.00159	CcSEcCtD
Acetylcysteine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000309	0.00159	CcSEcCtD
Acetylcysteine—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000308	0.00159	CcSEcCtD
Acetylcysteine—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000305	0.00157	CcSEcCtD
Acetylcysteine—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000304	0.00157	CcSEcCtD
Acetylcysteine—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000303	0.00156	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000302	0.00156	CcSEcCtD
Acetylcysteine—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000302	0.00155	CcSEcCtD
Acetylcysteine—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000302	0.00155	CcSEcCtD
Acetylcysteine—CHUK—Toll-like Receptor Signaling Pathway—CCL3—acquired immunodeficiency syndrome	0.0003	0.00903	CbGpPWpGaD
Acetylcysteine—CHUK—RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways—IFNA1—acquired immunodeficiency syndrome	0.000297	0.00893	CbGpPWpGaD
Acetylcysteine—IKBKB—TCR signaling in naïve CD8+ T cells—CD8A—acquired immunodeficiency syndrome	0.000293	0.00881	CbGpPWpGaD
Acetylcysteine—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000292	0.0015	CcSEcCtD
Acetylcysteine—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000292	0.0015	CcSEcCtD
Acetylcysteine—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000291	0.0015	CcSEcCtD
Acetylcysteine—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.00029	0.00149	CcSEcCtD
Acetylcysteine—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.00029	0.00149	CcSEcCtD
Acetylcysteine—Rash—Indinavir—acquired immunodeficiency syndrome	0.000288	0.00148	CcSEcCtD
Acetylcysteine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000287	0.00148	CcSEcCtD
Acetylcysteine—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000285	0.00147	CcSEcCtD
Acetylcysteine—IKBKB—IL-4 Signaling Pathway—IL4—acquired immunodeficiency syndrome	0.000284	0.00854	CbGpPWpGaD
Acetylcysteine—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000281	0.00145	CcSEcCtD
Acetylcysteine—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000278	0.00143	CcSEcCtD
Acetylcysteine—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000277	0.00143	CcSEcCtD
Acetylcysteine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000274	0.00141	CcSEcCtD
Acetylcysteine—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000273	0.0014	CcSEcCtD
Acetylcysteine—IKBKB—Toll-like Receptor Signaling Pathway—CCL3—acquired immunodeficiency syndrome	0.000272	0.00819	CbGpPWpGaD
Acetylcysteine—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000272	0.0014	CcSEcCtD
Acetylcysteine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000272	0.0014	CcSEcCtD
Acetylcysteine—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000271	0.0014	CcSEcCtD
Acetylcysteine—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.00027	0.00139	CcSEcCtD
Acetylcysteine—CHUK—Regulation of toll-like receptor signaling pathway—MBL2—acquired immunodeficiency syndrome	0.00027	0.00813	CbGpPWpGaD
Acetylcysteine—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.00027	0.00139	CcSEcCtD
Acetylcysteine—IKBKB—RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways—IFNA1—acquired immunodeficiency syndrome	0.000269	0.0081	CbGpPWpGaD
Acetylcysteine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000262	0.00135	CcSEcCtD
Acetylcysteine—Rash—Delavirdine—acquired immunodeficiency syndrome	0.00026	0.00134	CcSEcCtD
Acetylcysteine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.00026	0.00134	CcSEcCtD
Acetylcysteine—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.00026	0.00134	CcSEcCtD
Acetylcysteine—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000258	0.00133	CcSEcCtD
Acetylcysteine—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000256	0.00132	CcSEcCtD
Acetylcysteine—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000252	0.0013	CcSEcCtD
Acetylcysteine—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000248	0.00128	CcSEcCtD
Acetylcysteine—GRIN1—Spinal Cord Injury—IL4—acquired immunodeficiency syndrome	0.000248	0.00745	CbGpPWpGaD
Acetylcysteine—GRIN1—Axon guidance—ACTG1—acquired immunodeficiency syndrome	0.000247	0.00743	CbGpPWpGaD
Acetylcysteine—CHUK—B Cell Receptor Signaling Pathway—CD79A—acquired immunodeficiency syndrome	0.000247	0.00743	CbGpPWpGaD
Acetylcysteine—IKBKB—Regulation of toll-like receptor signaling pathway—MBL2—acquired immunodeficiency syndrome	0.000245	0.00737	CbGpPWpGaD
Acetylcysteine—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000245	0.00126	CcSEcCtD
Acetylcysteine—CHUK—Toll-like Receptor Signaling Pathway—IFNA1—acquired immunodeficiency syndrome	0.000244	0.00735	CbGpPWpGaD
Acetylcysteine—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000243	0.00125	CcSEcCtD
Acetylcysteine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000242	0.00125	CcSEcCtD
Acetylcysteine—CHUK—Canonical NF-kappaB pathway—TNF—acquired immunodeficiency syndrome	0.000242	0.00729	CbGpPWpGaD
Acetylcysteine—CHUK—EBV LMP1 signaling—TNF—acquired immunodeficiency syndrome	0.000242	0.00729	CbGpPWpGaD
Acetylcysteine—GRIN2B—Axon guidance—ACTG1—acquired immunodeficiency syndrome	0.000241	0.00725	CbGpPWpGaD
Acetylcysteine—Rash—Ritonavir—acquired immunodeficiency syndrome	0.00024	0.00124	CcSEcCtD
Acetylcysteine—SLCO1B1—Bile acid and bile salt metabolism—ALB—acquired immunodeficiency syndrome	0.00024	0.00724	CbGpPWpGaD
Acetylcysteine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.00024	0.00124	CcSEcCtD
Acetylcysteine—CHUK—Regulation of toll-like receptor signaling pathway—CCL3—acquired immunodeficiency syndrome	0.000234	0.00705	CbGpPWpGaD
Acetylcysteine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000233	0.0012	CcSEcCtD
Acetylcysteine—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000232	0.00119	CcSEcCtD
Acetylcysteine—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000231	0.00119	CcSEcCtD
Acetylcysteine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000231	0.00119	CcSEcCtD
Acetylcysteine—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—ALB—acquired immunodeficiency syndrome	0.00023	0.00693	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream TCR signaling—CD4—acquired immunodeficiency syndrome	0.000228	0.00685	CbGpPWpGaD
Acetylcysteine—IKBKB—Type II diabetes mellitus—TNF—acquired immunodeficiency syndrome	0.000228	0.00685	CbGpPWpGaD
Acetylcysteine—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000227	0.00117	CcSEcCtD
Acetylcysteine—IKBKB—B Cell Receptor Signaling Pathway—CD79A—acquired immunodeficiency syndrome	0.000224	0.00674	CbGpPWpGaD
Acetylcysteine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000223	0.00115	CcSEcCtD
Acetylcysteine—GSS—Metabolism—TAT—acquired immunodeficiency syndrome	0.000222	0.00668	CbGpPWpGaD
Acetylcysteine—IKBKB—Toll-like Receptor Signaling Pathway—IFNA1—acquired immunodeficiency syndrome	0.000222	0.00667	CbGpPWpGaD
Acetylcysteine—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000221	0.00114	CcSEcCtD
Acetylcysteine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000221	0.00114	CcSEcCtD
Acetylcysteine—IKBKB—EBV LMP1 signaling—TNF—acquired immunodeficiency syndrome	0.00022	0.00661	CbGpPWpGaD
Acetylcysteine—IKBKB—Canonical NF-kappaB pathway—TNF—acquired immunodeficiency syndrome	0.00022	0.00661	CbGpPWpGaD
Acetylcysteine—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000218	0.00112	CcSEcCtD
Acetylcysteine—IKBKB—Regulation of toll-like receptor signaling pathway—CCL3—acquired immunodeficiency syndrome	0.000212	0.00639	CbGpPWpGaD
Acetylcysteine—CHUK—TCR Signaling Pathway—CD8A—acquired immunodeficiency syndrome	0.000211	0.00636	CbGpPWpGaD
Acetylcysteine—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000208	0.00107	CcSEcCtD
Acetylcysteine—IKBKB—Downstream TCR signaling—CD4—acquired immunodeficiency syndrome	0.000206	0.00621	CbGpPWpGaD
Acetylcysteine—GRIN1—SIDS Susceptibility Pathways—IL10—acquired immunodeficiency syndrome	0.000204	0.00612	CbGpPWpGaD
Acetylcysteine—CHUK—Toll-like Receptor Signaling Pathway—CCL5—acquired immunodeficiency syndrome	0.000194	0.00584	CbGpPWpGaD
Acetylcysteine—CHUK—TCR Signaling Pathway—CCR5—acquired immunodeficiency syndrome	0.000193	0.00582	CbGpPWpGaD
Acetylcysteine—IKBKB—TCR Signaling Pathway—CD8A—acquired immunodeficiency syndrome	0.000192	0.00577	CbGpPWpGaD
Acetylcysteine—CHUK—Regulation of toll-like receptor signaling pathway—IFNA1—acquired immunodeficiency syndrome	0.000191	0.00574	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000189	0.00568	CbGpPWpGaD
Acetylcysteine—GRIN2D—Alzheimers Disease—TNF—acquired immunodeficiency syndrome	0.000186	0.00561	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by ERBB4—CXCL12—acquired immunodeficiency syndrome	0.000185	0.00558	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by Interleukins—CSF2—acquired immunodeficiency syndrome	0.000183	0.0055	CbGpPWpGaD
Acetylcysteine—CHUK—HIV-1 Nef: Negative effector of Fas and TNF-alpha—TNF—acquired immunodeficiency syndrome	0.000182	0.00546	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—ACTG1—acquired immunodeficiency syndrome	0.000176	0.0053	CbGpPWpGaD
Acetylcysteine—IKBKB—Toll-like Receptor Signaling Pathway—CCL5—acquired immunodeficiency syndrome	0.000176	0.0053	CbGpPWpGaD
Acetylcysteine—IKBKB—TCR Signaling Pathway—CCR5—acquired immunodeficiency syndrome	0.000175	0.00527	CbGpPWpGaD
Acetylcysteine—IKBKB—Regulation of toll-like receptor signaling pathway—IFNA1—acquired immunodeficiency syndrome	0.000173	0.00521	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—ACTG1—acquired immunodeficiency syndrome	0.000172	0.00517	CbGpPWpGaD
Acetylcysteine—CHUK—TCR signaling—CD4—acquired immunodeficiency syndrome	0.00017	0.00512	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by Interleukins—CSF2—acquired immunodeficiency syndrome	0.000166	0.00498	CbGpPWpGaD
Acetylcysteine—CHUK—TCR signaling in naïve CD4+ T cells—CD4—acquired immunodeficiency syndrome	0.000156	0.00468	CbGpPWpGaD
Acetylcysteine—IKBKB—TCR signaling—CD4—acquired immunodeficiency syndrome	0.000154	0.00464	CbGpPWpGaD
Acetylcysteine—GRIN2A—Alzheimers Disease—TNF—acquired immunodeficiency syndrome	0.000153	0.00461	CbGpPWpGaD
Acetylcysteine—CHUK—Regulation of toll-like receptor signaling pathway—CCL5—acquired immunodeficiency syndrome	0.000152	0.00456	CbGpPWpGaD
Acetylcysteine—CHUK—TWEAK Signaling Pathway—TNF—acquired immunodeficiency syndrome	0.00015	0.0045	CbGpPWpGaD
Acetylcysteine—GRIN1—Spinal Cord Injury—IFNG—acquired immunodeficiency syndrome	0.00015	0.0045	CbGpPWpGaD
Acetylcysteine—SLC7A11—Hemostasis—IFNA1—acquired immunodeficiency syndrome	0.000146	0.00438	CbGpPWpGaD
Acetylcysteine—CHUK—B Cell Activation—CD79A—acquired immunodeficiency syndrome	0.000141	0.00425	CbGpPWpGaD
Acetylcysteine—IKBKB—TCR signaling in naïve CD4+ T cells—CD4—acquired immunodeficiency syndrome	0.000141	0.00424	CbGpPWpGaD
Acetylcysteine—CHUK—TNF receptor signaling pathway —TNF—acquired immunodeficiency syndrome	0.000139	0.00419	CbGpPWpGaD
Acetylcysteine—IKBKB—Regulation of toll-like receptor signaling pathway—CCL5—acquired immunodeficiency syndrome	0.000137	0.00413	CbGpPWpGaD
Acetylcysteine—IKBKB—TWEAK Signaling Pathway—TNF—acquired immunodeficiency syndrome	0.000136	0.00408	CbGpPWpGaD
Acetylcysteine—GRIN1—Alzheimers Disease—TNF—acquired immunodeficiency syndrome	0.000133	0.00402	CbGpPWpGaD
Acetylcysteine—GRIN1—Spinal Cord Injury—IL2—acquired immunodeficiency syndrome	0.000133	0.004	CbGpPWpGaD
Acetylcysteine—GRIN2B—Alzheimers Disease—TNF—acquired immunodeficiency syndrome	0.00013	0.00392	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	0.000129	0.00388	CbGpPWpGaD
Acetylcysteine—IKBKB—B Cell Activation—CD79A—acquired immunodeficiency syndrome	0.000128	0.00385	CbGpPWpGaD
Acetylcysteine—SLC7A11—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	0.000126	0.0038	CbGpPWpGaD
Acetylcysteine—IKBKB—TNF receptor signaling pathway —TNF—acquired immunodeficiency syndrome	0.000126	0.0038	CbGpPWpGaD
Acetylcysteine—CHUK—TCR Signaling Pathway—CD4—acquired immunodeficiency syndrome	0.000121	0.00365	CbGpPWpGaD
Acetylcysteine—CHUK—TWEAK Signaling Pathway—IL6—acquired immunodeficiency syndrome	0.000121	0.00363	CbGpPWpGaD
Acetylcysteine—CHUK—Cardiac Hypertrophic Response—TNF—acquired immunodeficiency syndrome	0.000121	0.00363	CbGpPWpGaD
Acetylcysteine—CHUK—DAP12 interactions—HLA-B—acquired immunodeficiency syndrome	0.000118	0.00356	CbGpPWpGaD
Acetylcysteine—SLC7A11—Hemostasis—CSF2—acquired immunodeficiency syndrome	0.000114	0.00343	CbGpPWpGaD
Acetylcysteine—IKBKB—TCR Signaling Pathway—CD4—acquired immunodeficiency syndrome	0.00011	0.00331	CbGpPWpGaD
Acetylcysteine—IKBKB—TWEAK Signaling Pathway—IL6—acquired immunodeficiency syndrome	0.00011	0.0033	CbGpPWpGaD
Acetylcysteine—IKBKB—Cardiac Hypertrophic Response—TNF—acquired immunodeficiency syndrome	0.000109	0.00329	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—IFNA1—acquired immunodeficiency syndrome	0.000109	0.00328	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—ACTG1—acquired immunodeficiency syndrome	0.000105	0.00317	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—IFNA1—acquired immunodeficiency syndrome	9.88e-05	0.00297	CbGpPWpGaD
Acetylcysteine—GRIN1—Spinal Cord Injury—TNF—acquired immunodeficiency syndrome	9.68e-05	0.00291	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by Interleukins—IL2—acquired immunodeficiency syndrome	9.65e-05	0.0029	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—ACTG1—acquired immunodeficiency syndrome	9.55e-05	0.00287	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by Interleukins—IL2—acquired immunodeficiency syndrome	8.75e-05	0.00263	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—MBL2—acquired immunodeficiency syndrome	8.65e-05	0.0026	CbGpPWpGaD
Acetylcysteine—CHUK—MicroRNAs in cardiomyocyte hypertrophy—TNF—acquired immunodeficiency syndrome	8.6e-05	0.00259	CbGpPWpGaD
Acetylcysteine—CHUK—Apoptosis—TNF—acquired immunodeficiency syndrome	8.6e-05	0.00259	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—CSF2—acquired immunodeficiency syndrome	8.52e-05	0.00257	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—HLA-B—acquired immunodeficiency syndrome	8.2e-05	0.00247	CbGpPWpGaD
Acetylcysteine—CHUK—TNF alpha Signaling Pathway—TNF—acquired immunodeficiency syndrome	7.99e-05	0.00241	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—MBL2—acquired immunodeficiency syndrome	7.85e-05	0.00236	CbGpPWpGaD
Acetylcysteine—GRIN1—Spinal Cord Injury—IL6—acquired immunodeficiency syndrome	7.82e-05	0.00235	CbGpPWpGaD
Acetylcysteine—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—TNF—acquired immunodeficiency syndrome	7.8e-05	0.00235	CbGpPWpGaD
Acetylcysteine—IKBKB—Apoptosis—TNF—acquired immunodeficiency syndrome	7.8e-05	0.00235	CbGpPWpGaD
Acetylcysteine—GRIN1—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	7.75e-05	0.00233	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—CSF2—acquired immunodeficiency syndrome	7.73e-05	0.00233	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—APOBEC3G—acquired immunodeficiency syndrome	7.68e-05	0.00231	CbGpPWpGaD
Acetylcysteine—CHUK—TRAF6 Mediated Induction of proinflammatory cytokines—IL6—acquired immunodeficiency syndrome	7.6e-05	0.00229	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	7.55e-05	0.00227	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—HLA-B—acquired immunodeficiency syndrome	7.44e-05	0.00224	CbGpPWpGaD
Acetylcysteine—SLC7A11—Hemostasis—ALB—acquired immunodeficiency syndrome	7.42e-05	0.00223	CbGpPWpGaD
Acetylcysteine—CHUK—Toll-like Receptor Signaling Pathway—TNF—acquired immunodeficiency syndrome	7.36e-05	0.00221	CbGpPWpGaD
Acetylcysteine—IKBKB—TNF alpha Signaling Pathway—TNF—acquired immunodeficiency syndrome	7.25e-05	0.00218	CbGpPWpGaD
Acetylcysteine—IKBKB—TRAF6 Mediated Induction of proinflammatory cytokines—IL6—acquired immunodeficiency syndrome	6.89e-05	0.00207	CbGpPWpGaD
Acetylcysteine—CHUK—MyD88 cascade initiated on plasma membrane—IL6—acquired immunodeficiency syndrome	6.87e-05	0.00207	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	6.84e-05	0.00206	CbGpPWpGaD
Acetylcysteine—CHUK—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—acquired immunodeficiency syndrome	6.81e-05	0.00205	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—CCR2—acquired immunodeficiency syndrome	6.78e-05	0.00204	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—TAT—acquired immunodeficiency syndrome	6.75e-05	0.00203	CbGpPWpGaD
Acetylcysteine—ACY1—Metabolism—ALB—acquired immunodeficiency syndrome	6.74e-05	0.00203	CbGpPWpGaD
Acetylcysteine—CHUK—MyD88 dependent cascade initiated on endosome—IL6—acquired immunodeficiency syndrome	6.68e-05	0.00201	CbGpPWpGaD
Acetylcysteine—IKBKB—Toll-like Receptor Signaling Pathway—TNF—acquired immunodeficiency syndrome	6.67e-05	0.00201	CbGpPWpGaD
Acetylcysteine—CHUK—TCR Signaling Pathway—IL6—acquired immunodeficiency syndrome	6.56e-05	0.00198	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—CCNT1—acquired immunodeficiency syndrome	6.53e-05	0.00197	CbGpPWpGaD
Acetylcysteine—CHUK—Toll Like Receptor 9 (TLR9) Cascade—IL6—acquired immunodeficiency syndrome	6.45e-05	0.00194	CbGpPWpGaD
Acetylcysteine—CHUK—TNF alpha Signaling Pathway—IL6—acquired immunodeficiency syndrome	6.45e-05	0.00194	CbGpPWpGaD
Acetylcysteine—SLC7A11—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	6.42e-05	0.00193	CbGpPWpGaD
Acetylcysteine—CHUK—MyD88:Mal cascade initiated on plasma membrane—IL6—acquired immunodeficiency syndrome	6.34e-05	0.00191	CbGpPWpGaD
Acetylcysteine—GRIN1—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	6.25e-05	0.00188	CbGpPWpGaD
Acetylcysteine—IKBKB—MyD88 cascade initiated on plasma membrane—IL6—acquired immunodeficiency syndrome	6.23e-05	0.00188	CbGpPWpGaD
Acetylcysteine—IKBKB—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—acquired immunodeficiency syndrome	6.17e-05	0.00186	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—CCR2—acquired immunodeficiency syndrome	6.15e-05	0.00185	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—ACTG1—acquired immunodeficiency syndrome	6.13e-05	0.00185	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—IFNA1—acquired immunodeficiency syndrome	6.11e-05	0.00184	CbGpPWpGaD
Acetylcysteine—CHUK—MyD88-independent cascade—IL6—acquired immunodeficiency syndrome	6.08e-05	0.00183	CbGpPWpGaD
Acetylcysteine—IKBKB—MyD88 dependent cascade initiated on endosome—IL6—acquired immunodeficiency syndrome	6.06e-05	0.00182	CbGpPWpGaD
Acetylcysteine—SLC7A11—Hemostasis—IL2—acquired immunodeficiency syndrome	6.02e-05	0.00181	CbGpPWpGaD
Acetylcysteine—IKBKB—TCR Signaling Pathway—IL6—acquired immunodeficiency syndrome	5.95e-05	0.00179	CbGpPWpGaD
Acetylcysteine—CHUK—Toll-like Receptor Signaling Pathway—IL6—acquired immunodeficiency syndrome	5.94e-05	0.00179	CbGpPWpGaD
Acetylcysteine—IKBKB—TNF alpha Signaling Pathway—IL6—acquired immunodeficiency syndrome	5.85e-05	0.00176	CbGpPWpGaD
Acetylcysteine—IKBKB—Toll Like Receptor 9 (TLR9) Cascade—IL6—acquired immunodeficiency syndrome	5.85e-05	0.00176	CbGpPWpGaD
Acetylcysteine—IKBKB—MyD88:Mal cascade initiated on plasma membrane—IL6—acquired immunodeficiency syndrome	5.75e-05	0.00173	CbGpPWpGaD
Acetylcysteine—CHUK—Regulation of toll-like receptor signaling pathway—TNF—acquired immunodeficiency syndrome	5.75e-05	0.00173	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—AGPS—acquired immunodeficiency syndrome	5.74e-05	0.00173	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—CD79A—acquired immunodeficiency syndrome	5.69e-05	0.00171	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by Interleukins—IL6—acquired immunodeficiency syndrome	5.67e-05	0.00171	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—ACTG1—acquired immunodeficiency syndrome	5.56e-05	0.00167	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—IFNA1—acquired immunodeficiency syndrome	5.54e-05	0.00167	CbGpPWpGaD
Acetylcysteine—IKBKB—MyD88-independent cascade—IL6—acquired immunodeficiency syndrome	5.52e-05	0.00166	CbGpPWpGaD
Acetylcysteine—CHUK—Activated TLR4 signalling—IL6—acquired immunodeficiency syndrome	5.47e-05	0.00165	CbGpPWpGaD
Acetylcysteine—SLC22A6—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	5.43e-05	0.00164	CbGpPWpGaD
Acetylcysteine—IKBKB—Toll-like Receptor Signaling Pathway—IL6—acquired immunodeficiency syndrome	5.39e-05	0.00162	CbGpPWpGaD
Acetylcysteine—IKBKB—Regulation of toll-like receptor signaling pathway—TNF—acquired immunodeficiency syndrome	5.21e-05	0.00157	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—CD79A—acquired immunodeficiency syndrome	5.16e-05	0.00155	CbGpPWpGaD
Acetylcysteine—CHUK—Toll Like Receptor 4 (TLR4) Cascade—IL6—acquired immunodeficiency syndrome	5.15e-05	0.00155	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by Interleukins—IL6—acquired immunodeficiency syndrome	5.14e-05	0.00155	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—IFNG—acquired immunodeficiency syndrome	5.07e-05	0.00153	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—MBL2—acquired immunodeficiency syndrome	5.04e-05	0.00152	CbGpPWpGaD
Acetylcysteine—IKBKB—Activated TLR4 signalling—IL6—acquired immunodeficiency syndrome	4.96e-05	0.00149	CbGpPWpGaD
Acetylcysteine—SLCO1B1—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	4.94e-05	0.00149	CbGpPWpGaD
Acetylcysteine—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—IL6—acquired immunodeficiency syndrome	4.67e-05	0.0014	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—CD40LG—acquired immunodeficiency syndrome	4.64e-05	0.0014	CbGpPWpGaD
Acetylcysteine—CHUK—Regulation of toll-like receptor signaling pathway—IL6—acquired immunodeficiency syndrome	4.64e-05	0.0014	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—HLA-B—acquired immunodeficiency syndrome	4.6e-05	0.00138	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—IFNG—acquired immunodeficiency syndrome	4.6e-05	0.00138	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—CD8A—acquired immunodeficiency syndrome	4.59e-05	0.00138	CbGpPWpGaD
Acetylcysteine—CHUK—Toll-Like Receptors Cascades—IL6—acquired immunodeficiency syndrome	4.58e-05	0.00138	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by SCF-KIT—IL6—acquired immunodeficiency syndrome	4.58e-05	0.00138	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	4.57e-05	0.00138	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	4.57e-05	0.00138	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—MBL2—acquired immunodeficiency syndrome	4.57e-05	0.00138	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—IL2—acquired immunodeficiency syndrome	4.5e-05	0.00136	CbGpPWpGaD
Acetylcysteine—IKBKB—MAPK Signaling Pathway—TNF—acquired immunodeficiency syndrome	4.48e-05	0.00135	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	4.46e-05	0.00134	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—HLA-B—acquired immunodeficiency syndrome	4.42e-05	0.00133	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signaling of activated FGFR—IL6—acquired immunodeficiency syndrome	4.39e-05	0.00132	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by ERBB4—IL6—acquired immunodeficiency syndrome	4.32e-05	0.0013	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—CD40LG—acquired immunodeficiency syndrome	4.21e-05	0.00127	CbGpPWpGaD
Acetylcysteine—IKBKB—Regulation of toll-like receptor signaling pathway—IL6—acquired immunodeficiency syndrome	4.2e-05	0.00127	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—HLA-B—acquired immunodeficiency syndrome	4.17e-05	0.00125	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—CD8A—acquired immunodeficiency syndrome	4.16e-05	0.00125	CbGpPWpGaD
Acetylcysteine—IKBKB—Toll-Like Receptors Cascades—IL6—acquired immunodeficiency syndrome	4.16e-05	0.00125	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	4.15e-05	0.00125	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	4.15e-05	0.00125	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	4.14e-05	0.00124	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signal transduction—IL6—acquired immunodeficiency syndrome	4.12e-05	0.00124	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by FGFR—IL6—acquired immunodeficiency syndrome	4.1e-05	0.00123	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—IL2—acquired immunodeficiency syndrome	4.08e-05	0.00123	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by ERBB2—IL6—acquired immunodeficiency syndrome	4.08e-05	0.00123	CbGpPWpGaD
Acetylcysteine—CHUK—DAP12 signaling—IL6—acquired immunodeficiency syndrome	4.06e-05	0.00122	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—HLA-B—acquired immunodeficiency syndrome	4e-05	0.0012	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CCR2—acquired immunodeficiency syndrome	3.95e-05	0.00119	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—ALB—acquired immunodeficiency syndrome	3.87e-05	0.00116	CbGpPWpGaD
Acetylcysteine—CHUK—DAP12 interactions—IL6—acquired immunodeficiency syndrome	3.82e-05	0.00115	CbGpPWpGaD
Acetylcysteine—CHUK—Fc epsilon receptor (FCERI) signaling—IL6—acquired immunodeficiency syndrome	3.82e-05	0.00115	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by FGFR in disease—IL6—acquired immunodeficiency syndrome	3.82e-05	0.00115	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by EGFR—IL6—acquired immunodeficiency syndrome	3.79e-05	0.00114	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by EGFR in Cancer—IL6—acquired immunodeficiency syndrome	3.75e-05	0.00113	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	3.75e-05	0.00113	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by PDGF—IL6—acquired immunodeficiency syndrome	3.74e-05	0.00112	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CCR2—acquired immunodeficiency syndrome	3.58e-05	0.00108	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—IFNA1—acquired immunodeficiency syndrome	3.56e-05	0.00107	CbGpPWpGaD
Acetylcysteine—GRIN1—Axon guidance—IL6—acquired immunodeficiency syndrome	3.48e-05	0.00105	CbGpPWpGaD
Acetylcysteine—IKBKB—Fc epsilon receptor (FCERI) signaling—IL6—acquired immunodeficiency syndrome	3.47e-05	0.00104	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CD79A—acquired immunodeficiency syndrome	3.45e-05	0.00104	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—CXCR4—acquired immunodeficiency syndrome	3.43e-05	0.00103	CbGpPWpGaD
Acetylcysteine—GRIN2B—Axon guidance—IL6—acquired immunodeficiency syndrome	3.4e-05	0.00102	CbGpPWpGaD
Acetylcysteine—CHUK—NGF signalling via TRKA from the plasma membrane—IL6—acquired immunodeficiency syndrome	3.38e-05	0.00102	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—IFNA1—acquired immunodeficiency syndrome	3.23e-05	0.000971	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CD79A—acquired immunodeficiency syndrome	3.13e-05	0.000942	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—TNF—acquired immunodeficiency syndrome	3.08e-05	0.000927	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—TNF—acquired immunodeficiency syndrome	3e-05	0.000904	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.83e-05	0.00085	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CD40LG—acquired immunodeficiency syndrome	2.82e-05	0.000847	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CD8A—acquired immunodeficiency syndrome	2.78e-05	0.000838	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CSF2—acquired immunodeficiency syndrome	2.78e-05	0.000838	CbGpPWpGaD
Acetylcysteine—SLC22A6—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	2.76e-05	0.000831	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—CD4—acquired immunodeficiency syndrome	2.75e-05	0.000826	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—HLA-B—acquired immunodeficiency syndrome	2.68e-05	0.000806	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—IL6—acquired immunodeficiency syndrome	2.65e-05	0.000797	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	2.64e-05	0.000795	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—CD4—acquired immunodeficiency syndrome	2.64e-05	0.000793	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—IL6—acquired immunodeficiency syndrome	2.6e-05	0.000783	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.56e-05	0.000771	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.56e-05	0.000769	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CD40LG—acquired immunodeficiency syndrome	2.55e-05	0.000768	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CSF2—acquired immunodeficiency syndrome	2.52e-05	0.00076	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CD8A—acquired immunodeficiency syndrome	2.52e-05	0.00076	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	2.51e-05	0.000756	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—CD4—acquired immunodeficiency syndrome	2.49e-05	0.000749	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—IL6—acquired immunodeficiency syndrome	2.49e-05	0.000748	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—HLA-B—acquired immunodeficiency syndrome	2.43e-05	0.000731	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—IL6—acquired immunodeficiency syndrome	2.42e-05	0.000729	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.4e-05	0.000723	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.4e-05	0.000723	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—IL6—acquired immunodeficiency syndrome	2.4e-05	0.000722	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—CD4—acquired immunodeficiency syndrome	2.39e-05	0.000719	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—IL6—acquired immunodeficiency syndrome	2.36e-05	0.00071	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—CCR5—acquired immunodeficiency syndrome	2.35e-05	0.000707	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.32e-05	0.000697	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.18e-05	0.000655	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.18e-05	0.000655	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.83e-05	0.00055	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.8e-05	0.000542	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.66e-05	0.000499	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—IFNG—acquired immunodeficiency syndrome	1.66e-05	0.000498	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.65e-05	0.000495	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.63e-05	0.000491	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CD4—acquired immunodeficiency syndrome	1.6e-05	0.000481	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—IFNG—acquired immunodeficiency syndrome	1.5e-05	0.000452	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.49e-05	0.000449	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—IL6—acquired immunodeficiency syndrome	1.48e-05	0.000447	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—CD4—acquired immunodeficiency syndrome	1.48e-05	0.000444	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—IL2—acquired immunodeficiency syndrome	1.47e-05	0.000443	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CD4—acquired immunodeficiency syndrome	1.45e-05	0.000436	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—IL6—acquired immunodeficiency syndrome	1.35e-05	0.000405	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—IL2—acquired immunodeficiency syndrome	1.33e-05	0.000401	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—ALB—acquired immunodeficiency syndrome	1.18e-05	0.000354	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—IL2—acquired immunodeficiency syndrome	9.51e-06	0.000286	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—IL6—acquired immunodeficiency syndrome	8.65e-06	0.00026	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—IL2—acquired immunodeficiency syndrome	8.63e-06	0.00026	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—IL6—acquired immunodeficiency syndrome	7.98e-06	0.00024	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—IL6—acquired immunodeficiency syndrome	7.84e-06	0.000236	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.59e-06	0.000168	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.07e-06	0.000153	CbGpPWpGaD
